Background Oral anticoagulation (OAC) effectively reduces stroke risk in patients with atrial fibrillation (AF), but its use ...

Objective: To identify what patient and carer characteristics influence transition into residential care for people with dementia. Method: Longitudinal study of a cohort of people with dementia and ...

1 Department of Neurology, Erasmus Medical Centre, Rotterdam, The Netherlands 2 Department of Neuropathology, Vrije Universiteit Medical Centre, Amsterdam, The Netherlands Correspondence to Dr John C.

Background Benign multiple sclerosis (MS), characterised by minimal disability despite long disease duration, remains poorly understood in terms of its determinants and prognostic implications. While ...

Background Smoking is a significant risk factor for neurological disorders, yet its global impact on these conditions remains underexplored. Methods Using Global Burden of Diseases 2021 data, we ...

Evidence is presented that patients with prosopagnosia have right anterior inferior occipital lesions in the region of the occipital temporal junction. Many if not all cases have an additional lesion ...

Correspondence to Dr P Bede, Smurfit Building, Clinical Research Centre, Beaumont Hospital, Dublin 9, Dublin, Ireland; bedepeter{at}hotmail.com Background Amyotrophic lateral sclerosis (ALS) is a ...

Correspondence to Dr William Stewart, Department of Neuropathology, NHS Greater Glasgow and Clyde, Glasgow G51 4TF, UK; william.stewart{at}glasgow.ac.uk Introduction There is growing recognition of an ...

Background A few case reports have shown controversial results of rituximab efficacy in patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Objective To analyse the ...

1 Department of Neurosurgery, Pundang CHA Hospital, College of Medicine, Pochon CHA University, 351 Yatapdong, Pundangku, Sungnam 463-712, Korea 2 Department of Radiology, Pundang CHA Hospital, ...

Professor G Deuschl, Neurologische Klinik der Christian-Albrechts-Universität, Niemannsweg 147, D-24105 Kiel, Germany. Telephone 0049 431 597 2610; fax 0049 431 597 2712. OBJECTIVES Botulinum toxin ...

Tremor is one of the clinical manifestations of dystonia; however, there are no specific therapeutic trials evaluating the efficacy of treatments for dystonic tremor (DT), tremor associated with ...